{"abstract":"The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public meeting entitled \"Use of Orally Ingestible Unapproved Prescription Drug Products Containing Fluoride in the Pediatric Population.\" The purpose of the hybrid public meeting is to seek public input on the clinical use and safety concerns associated with the use of orally ingestible unapproved prescription drug products containing fluoride in the pediatric population. The public meeting will be facilitated by the Reagan-Udall Foundation for the FDA. FDA is establishing a docket for public comment on this topic.","action":"Notice of public meeting; establishment of a public docket; request for comments.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2025/06/16/2025-10943.html","cfr_references":[],"citation":"90 FR 25329","comment_url":null,"comments_close_on":"2025-07-16","correction_of":null,"corrections":[],"dates":"The public meeting will be held in person and virtually on July 23, 2025, from 9:30 a.m. to 4:00 p.m. Eastern Time. Either electronic or written comments on this public meeting must be submitted by July 16, 2025. See the SUPPLEMENTARY INFORMATION section for registration date and information.","disposition_notes":null,"docket_ids":["Docket No. FDA-2025-N-1557"],"dockets":[{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":4604,"comment_start_date":"2025-06-16","updated_at":"2025-07-31T01:56:26.021-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2025-N-1557-0001","allow_late_comments":false,"id":"FDA-2025-N-1557-0001","comment_end_date":"2025-07-17","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2025-N-1557","title":"Use of Orally Ingestible Unapproved Prescription Drug Products Containing Fluoride in the Pediatric Population; Public Meeting; Establishment of a Public Docket; Request for Comments"}],"document_number":"2025-10943","effective_on":null,"end_page":25331,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2025/06/16/2025-10943.xml","html_url":"https://www.federalregister.gov/documents/2025/06/16/2025-10943/use-of-orally-ingestible-unapproved-prescription-drug-products-containing-fluoride-in-the-pediatric","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2025-10943?publication_date=2025-06-16","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2025-06-16/2025-10943/mods.xml","not_received_for_publication":null,"page_length":3,"page_views":{"count":3720,"last_updated":"2026-09-22 10:15:08 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-06-16/pdf/2025-10943.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-10943.pdf?1749818723","publication_date":"2025-06-16","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2025/06/16/2025-10943.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":4604,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2025-N-1557","supporting_documents_count":0,"docket_id":"FDA-2025-N-1557","document_id":"FDA-2025-N-1557-0001","regulation_id_number":null,"title":"Use of Orally Ingestible Unapproved Prescription Drug Products Containing Fluoride in the Pediatric Population; Public Meeting; Establishment of a Public Docket; Request for Comments","checked_regulationsdotgov_at":"2025-08-01T08:55:03Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":25329,"subtype":null,"title":"Use of Orally Ingestible Unapproved Prescription Drug Products Containing Fluoride in the Pediatric Population; Public Meeting; Establishment of a Public Docket; Request for Comments","toc_doc":"Use of Orally Ingestible Unapproved Prescription Drug Products Containing Fluoride in the Pediatric Population","toc_subject":"Hearings, Meetings, Proceedings, etc.","topics":[],"type":"Notice","volume":90}